tirzepatide study once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Tirzepatide for the Treatment of

Last Published 10.31.2025 Effective Date: 11.01.2025 This policy addresses the use of specialty pharmacy medications administered by the intravitreal route for certain ophthalmologic conditions

You have a BMI that may qualify: Many prescription weight loss medications are considered for adults with a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related condition

Naltrexone for AUD comes as both a daily pill and a monthly intramuscular shot (Vivitrol), and the monthly form consistently outperforms the daily one for the same reason: people who have stopped drinking actually stay on it

"Ideally, we want patients to lose adipose tissue and preserve their lean body mass

Body composition starts shifting in ways the scale does not fully capture, fat loss outpaces lean mass loss by a ratio of roughly 3 to 1, meaning for every 4 pounds lost, about 3 are fat and 1 is lean tissue

Vacations and holidays The longest and most challenging drinking scenarios